Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-005208
Filing Date
2025-11-18
Accepted
2025-11-18 16:31:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4801
  Complete submission text file 0001172661-25-005208.txt   6444
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
CYPHERPUNK TECHNOLOGIES INC. (Subject) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90188 | Film No.: 251495214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2535 RAWLEY PIKE ROCKINGHAM VA 22801
Business Address
Severns Sean Michael (Filed by) CIK: 0002097203 (see all company filings)

Type: SCHEDULE 13G